BioReference Laboratories
FDA Approves Opko Health 4KScore Prostate Cancer Test
The test is approved for men 45 and older who haven't had a previous prostate biopsy or are biopsy negative.
Opko Health Q3 Revenues Fall 10 Percent
Despite decreases in COVID-19 testing volume, the firm saw an increase in clinical and genomic test revenue.
With the COVID-19 pandemic driving new investment and uptake of telemedicine, more providers are looking to offer their patients easy access to lab testing.
360Dx Index Maintains Steady Ascent, Increasing 3 Percent in August
Of the 29 companies in the index, 18 saw increases in their stock prices, while 11 saw declines.
BioReference Labs Acquires US Ariosa Lab NIPT Business From Roche
The business will complement BioReference's specialty health division GenPath, which offers a noninvasive prenatal screening test.
May 6, 2021
Apr 29, 2021
Apr 7, 2021
Jan 21, 2021
Oct 30, 2020